NCT04445441View on ClinicalTrials.gov

An Observational Study to Assess the Protocol for the COVID-19 Treatment in Burkina Faso

CompletedOBSERVATIONAL
Enrollment

153

Participants

Timeline

Start Date

April 24, 2020

Primary Completion Date

September 3, 2020

Study Completion Date

November 30, 2020

Conditions
Coronavirus Infection
Trial Locations (2)

15

Tingadogo University Hospital, Ouagadougou

01

Sourou Sanon University Hospital, Bobo-Dioulasso

All Listed Sponsors
lead

Centre Muraz

OTHER

NCT04445441 - An Observational Study to Assess the Protocol for the COVID-19 Treatment in Burkina Faso | Biotech Hunter | Biotech Hunter